Vontobel Holding Ltd. Crispr Therapeutics Ag Transaction History

Vontobel Holding Ltd.

$29.2 Billion
Q3 2024

A detailed history of Vontobel Holding Ltd. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Vontobel Holding Ltd. holds 16,957 shares of CRSP stock, worth $694,219. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,957

Previous 16,357 3.67%

Holding current value

$694,219

Previous $883,000 9.85%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$44.62 - $62.75 $26,772 - $37,650	600 Added 3.67%	16,957 $796,000
Q2 2024 Aug 13, 2024	SELL	$51.17 - $68.18 $74,196 - $98,861	-1,450 Reduced 8.14%	16,357 $883,000
Q1 2024 May 10, 2024	SELL	$60.67 - $89.12 $2,851 - $4,188	-47 Reduced 0.26%	17,807 $1.21 Million
Q4 2023 Jun 03, 2024	SELL	$38.62 - $72.18 $21,202 - $39,626	-549 Reduced 2.98%	17,854 $1.12 Million
Q4 2023 Jan 29, 2024	SELL	$38.62 - $72.18 $21,202 - $39,626	-549 Reduced 2.98%	17,854 $1.12 Million
Q3 2023 Jun 03, 2024	SELL	$45.39 - $59.0 $22,558 - $29,323	-497 Reduced 2.63%	18,403 $835,000
Q3 2023 Oct 10, 2023	SELL	$45.39 - $59.0 $22,558 - $29,323	-497 Reduced 2.63%	18,403 $835,000
Q2 2023 Jun 03, 2024	BUY	$43.47 - $67.77 $10,824 - $16,874	249 Added 1.34%	18,900 $1.06 Million
Q2 2023 Jul 24, 2023	BUY	$43.47 - $67.77 $10,824 - $16,874	249 Added 1.34%	18,900 $1.06 Million
Q1 2023 Jun 03, 2024	BUY	$41.0 - $56.12 $34,604 - $47,365	844 Added 4.74%	18,651 $843,000
Q1 2023 Apr 12, 2023	SELL	$41.0 - $56.12 $109,921 - $150,457	-2,681 Reduced 12.57%	18,651 $843,000
Q4 2022 Feb 14, 2023	BUY	$39.19 - $65.67 $103,579 - $173,565	2,643 Added 14.14%	21,332 $867,000
Q3 2022 Nov 04, 2022	SELL	$61.1 - $83.78 $95,682 - $131,199	-1,566 Reduced 7.73%	18,689 $1.22 Million
Q2 2022 Jul 27, 2022	SELL	$43.23 - $73.83 $47,769 - $81,582	-1,105 Reduced 5.17%	20,255 $1.28 Million
Q1 2022 May 13, 2022	SELL	$53.19 - $79.24 $272,279 - $405,629	-5,119 Reduced 19.33%	21,360 $1.37 Million
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $326,899 - $519,056	4,664 Added 21.38%	26,479 $2.09 Million
Q3 2021 Oct 29, 2021	BUY	$110.2 - $156.64 $346,468 - $492,476	3,144 Added 16.84%	21,815 $2.44 Million
Q2 2021 Aug 06, 2021	BUY	$100.84 - $161.89 $1.88 Million - $3.02 Million	18,671 New	18,671 $2.81 Million

Others Institutions Holding CRSP

# of Institutions

490

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.19B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.

Account

Vontobel Holding Ltd. Crispr Therapeutics Ag Transaction History